Showing results (481-490 of 495) with videos related to
Sort By:
Pageof 50
Endoscopy International Open|August 15, 2018
Peroral endoscopic myotomy is effective and safe in non-achalasia esophageal motility disorders: an international multicenter studyMouen A Khashab, Pietro Familiari, Peter V Draganov, et al.Cancer Immunology Research|June 7, 2023
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal HyperexpansionPoonam N Desai, Bofei Wang, Andre Fonseca, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 30, 2020
Tenacious Endemic Typhoid Fever in SamoaMichael J Sikorski, Sachin N Desai, Siaosi Tupua, et al.Cancer Immunology Research|May 10, 2023
Single-Cell Profiling of CD8+ T Cells in Acute Myeloid Leukemia Reveals a Continuous Spectrum of Differentiation and Clonal HyperexpansionPoonam N Desai, Bofei Wang, Andre Fonseca, et al.The New England Journal of Medicine|May 5, 2016
Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in BangladeshFirdausi Qadri, Thomas F Wierzba, Mohammad Ali, et al.The Journal of Clinical Investigation|September 19, 2018
Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutritionHu Huang, Seung-Hwan Lee, Inês Sousa-Lima, et al.Gastrointestinal Endoscopy|March 25, 2018
Retraction notice to "Long-term outcomes of per-oral endoscopic myotomy in patients with achalasia with a minimum follow-up of 2 years: an international multicenter study": [YMGE 85 (2017) 927-933]Saowanee Ngamruengphong, Haruhiro Inoue, Philip Wai-Yan Chiu, et al.Gastrointestinal Endoscopy|September 25, 2016
Long-term outcomes of per-oral endoscopic myotomy in patients with achalasia with a minimum follow-up of 2 years: an international multicenter studySaowanee Ngamruengphong, Haruhiro Inoue, Philip Wai-Yan Chiu, et al.Circulation Research|April 15, 2026
Metabolomics of Right Ventricular Function in Pulmonary HypertensionJonathan Chacon-Barahona, Samuel J Chung, Jonah D Garry, et al.Journal of Medicinal Chemistry|February 26, 2000
Structure-activity relationship studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a potent inhibitor of leukotriene A(4) (LTA(4)) hydrolaseT D Penning, N S Chandrakumar, B B Chen, et al.Pageof 50